Intelence 100 mg/1
etravirine · TABLET · Janssen Products LP
Intelence (etravirine) is a prescription tablet taken by mouth to treat HIV-1 infection as part of combination antiretroviral therapy. It works by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate in the body.
Key Facts
- Brand Name
- Intelence
- Generic Name
- etravirine
- NDC Code (Product)
59676-570- Manufacturer
- Janssen Products LP
- Strength
- 100 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA022187
- Drug Class
- Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 01/18/2008
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is Intelence used for?
Intelence (etravirine) is a prescription tablet taken by mouth to treat HIV-1 infection as part of combination antiretroviral therapy. It works by inhibiting reverse transcriptase, an enzyme that HIV uses to replicate in the body.
Is Intelence a controlled substance?
Intelence is not classified as a controlled substance by the DEA.
What is the generic name for Intelence?
The generic name for Intelence is etravirine. There are 10 other brand versions of etravirine.
What is the NDC code for Intelence 100 mg/1?
The NDC (National Drug Code) for Intelence 100 mg/1 is 59676-570, listed by Janssen Products LP.